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fThe International Society for Pharmacoeconomics and Outcomes
Research Good Research Practices for Conjoint Analysis Task
Force was established to identify good research practices for ap-
plications of conjoint analysis (CA) in health. The report contains a
discussion of issues raised when conducting such a study and
presents a checklist for CA applications in health.
The ISPOR report begins by summarising applications of CA in
health, noting the broad range of applications. For a recent review
of such applications see de Bekker et al. [1]. Whilst CA was intro-
duced into health to value characteristics beyond health out-
comes, the technique now has a much broader use. de Bekker et al.
[1] note the absence of CA within an economic evaluation frame-
work. Quality-adjusted life years (QALYs) continue to be the pre-
ferred valuation method by bodies such as the National Institute
for Health and Clinical Excellence. This is despite the increasing
recognition of the importance of valuing the patient experience in
the delivery of health care. Because CA can value patient experi-
ence aspects of care as well as health outcomes—and indeed the
trade-offs between them—the increasing use of well conducted
CA studies will hopefully lead to their increased use at the policy
level. Thus, it is important that good practice is established when
conducting CA studies. The checklist provided by the task force
provides a useful guide to conducting a good CA study, as does the
User Guide to conducting such studies published by Lancsar and
Louviere [2].
As noted by the authors of the report, CA is an attribute-based
measure of value. The key stages when conducting a study can be
broadly defined as defining attributes and levels, determining
choices to present to respondents (experimental design), develop-
ment and administration of questionnaire, and analysis and inter-
pretation of data. The task force discusses a number of issues
across these stages when developing their checklist. Given the
broad range of issues raised when applying CA, discussion of
many of them is necessarily brief. The authors provide a useful list
of references. Below I discuss some of the issues raised in a little
more detail, highlighting additional points and useful reading. As
pointed out by the task force, many of the issues raised in the
report reflect the principles of a good survey design, and apply to
all valuation methods.
Deriving attributes and levels is one of the most important
stages when conducting a CA study. The most efficient experi-
mental design and sophisticated form of econometric analysis
cannot compensate if the attributes and levels are wrong. It is
becoming increasingly important, when reporting attributes and
levels, to report in detail how they were derived. Where qualitative
work is employed, it is necessary to report a systematic and valid
framework for analysis of such data. It is no longer sufficient to
say, “Qualitative work was used to derive the attributes and levels,
and they are shown in Table 1.” The report notes that “If the num-
ber of possible attributes exceeds what one may find possible to
pilot in a conjoint analysis . . ..” It is worth noting here that this
restriction on the number of attributes refers to an assumption of tthe CA approach that individuals consider all the attributes, and
make trade-offs. It is this assumption that allows the researcher to
estimate the value of attributes; that is, how much money an in-
dividual would be willing to give up to have a lower waiting time.
If “too many” attributes are included, there is concern that individu-
als will resort to simple decision-making strategies, such as always
choose the cheapest option. Estimation of trade-offs, whilst possible
at the analysis stage, would then not be valid.
When discussing possible approaches to deriving choice sets
(experimental design methods), the authors note that resulting
designs may include implausible combinations. They give the ex-
ample of an orthogonal design, including a profile that combines
severe nausea with no restrictions on activities of daily life. Meth-
ods exist for creating designs with restrictions, including nesting
[2] and use of software packages such as SAS [3] and Ngene (http://
ww.choice-metrics.com/). This is an example of trading off re-
pondent efficiency and statistical efficiency, as the authors note.
A few additional points that are not mentioned in the report
re worth noting with regard to experimental design. In addition
o the design methods mentioned, readily available designs exist
1]. A recent development in the design literature is to use prior
ssumptions about parameters (which can be obtained from pilot
ork) to improve efficiency. If the researcher wants to include
nteraction terms (i.e., preferences for one attribute depend on the
evels of another attribute), this must be stated at the experimen-
al design stage. The importance of testing for interaction terms is
eing increasingly recognised. For more on all these issues see de
ekker et al. [1].
The report considers the important issue of whether or not to
nclude an opt-out or status-quo option within the choice sets
which would be added to the choices derived from the experi-
ental design), stating, “The inclusion of an opt-out or status-quo
ption may be inappropriate for many types of research questions
n health care.” It is becoming increasingly recognized that for
ost CA health applications an opt-out/status-quo option is nec-
ssary. This is important when a cost attribute (or price proxy) is
ncluded, such that willingness to pay (a monetary measure of
enefit) can be indirectly estimated (as is the case for many appli-
ations of CA in health). Failure to include an opt-out/status-quo
ption in such studies will misrepresent demand (because indi-
iduals may be forced to choose an option that is above their max-
mum willingness to pay). Forced choices may be more appropri-
te when individuals are being asked which options they prefer, as
pposed to which options they would choose, and a price proxy is
ot included as an attribute. Examples may include using CA to
stimate weights within the QALY framework, develop priority
etting frameworks, and establish health professional preferences
or treatment of patients [1]. When a researcher includes an opt-
ut or status-quo option, it is crucial to have information on the
evels of the attributes for such options. Failure to have such in-
ormation will result in the researcher not being able to analyse
he opt-out /status-quo responses.
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402 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 4 0 1 – 4 0 2The authors further argue that ‘“. . . the inclusion of an opt-out
or status-quo option may have serious implications for the exper-
imental design.” I believe this statement is a bit strong. The au-
thors are correct to note that the inclusion of the opt-out or status-
quo option will compromise the statistical design properties.
Where levels for the opt out/status quo are known in advance of data
collection the implications for the efficiency of the design can be
estimated in advance. It is also advisable to simulate response data
and test that the desired model can be estimated. Where the opt-out
levels are constant across respondents, the affect on the design effi-
ciency is smaller. Where information is collected from individuals
within the study on their current situation/status quo, and this var-
ies across respondents, the effect on the statistical efficiency of the
design is likely to be greater and cannot be estimated in advance of
data collection. However, this is another example of where re-
spondent efficiency will have been gained (because the choices
presented are more realistic) at the expense of statistical effi-
ciency, and the benefits are likely to outweigh the costs.
The report discusses response rates and incentives. The authors
argue that “It is good practice to provide a respondent with incentive
for participation in the survey in a manner that is in compliance with
ethical guidelines.” To date very few CA studies have offered incen-
tives for completion. Within a publicly provided health care system
the incentive is often to inform respondents that information on
their preferences will influence the provision of health care. Personal
experience, however, suggests that response rates to CA studies are
falling, and methods to increase response rates do need to be consid-
ered. Incentives may therefore be considered, and research should
test the effectiveness of different incentives.
The authors note that researchers need to address how the
independent variables are coded, distinguishing between categor-
ical and continuous variables. It is worth noting that estimation of
trade-offs can only be conducted when a continuous variable is mod-
elled. This continuous variable is most commonly price, but risk and
time have also been used in health applications of CA [1]. Further-
more, for discussion of the pros and cons of effects coding versus
dummy variable coding, the reader should see Bech and Gyrd Han-
sen [4] and for an application of effects coding see Watson et al. [5].
Conditional logit continues to be the most common method for
nalyzing CA response data [2]. The report identifies a number of
ore sophisticated analytical approaches, including mixed-logit
nd latent class, which drop some of the assumptions of the con-
itional logit model and allow for unobserved preference hetero-
eneity. I often wonder how useful such information is to policy
akers because it is not possible to identify where preferences
iffer. A more useful approach may be to use conditional logit to
ain better insight into observed variation that can potentially be
cted upon by policy makers. The authors also mention Hierarchi-
al Bayes for estimating preference parameters for each respon-
ent. This approach is applicable when individuals are presented
ith all choices derived from the experimental design, although it
oes raise the issue of the extent to which policy can be developed
t the individual level. However, when a blocked design is used,
nd individuals are presented with a fraction of the fractional fac-
orial design, this approach is not appropriate.
Because CA relies on responses to hypothetical choices, it is
mportant to check the validity of responses. Given the lack of aarket for health care, tests of internal validity dominate. The
eport notes that such tests include repeated choices, dominant
hoices, transitivity tests, and nontrading responses (always
hoosing the alternative with the best level of a given attribute).
en’s expansion and contraction properties are also beginning to
e applied and it is common practice to check if the signs of esti-
ated parameters are consistent with a priori expectations [1,2].
he authors note that it is generally better to include statistical
ontrols to allow for failures (rather than simply dropping respon-
ents). It is also worth noting that qualitative work has found that
ndividuals defined as failing such tests had “rational” reasons for
oing so [1]. Lancsar and Louviere [2] note that random utility
odels are robust to violations of compensatory decision making
nd errors made by individuals in forming and revealing prefer-
nces, supporting the authors of this report.
I argue that the greatest challenge facing practitioners of CA is
o test the external validity of responses; that is, the extent to
hich respondents behave in reality as they state in a hypotheti-
al context. There has been very little research in this area [1],
robably reflecting the difficulty of investigating this question in a
ublicly provided health care system where individuals have lim-
ted choice and do not pay at the point of consumption. Possible
reas for future research include field experiments comparing re-
ealed and stated choices for private health care goods, as well
aboratory and classroom experiments [1]. Such research would
elp provide further guidance on good practice, and lend more
redibility and confidence to results from well-conducted CA stud-
es that follow good research practice (as described in this report
nd Lancsar and Louviere [2]). This would hopefully lead to the
ncreased use of CA at the policy level, challenging the QALY as the
ain valuation method within economic evaluations.
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